Compare Jasuindo Tiga Perkasa Tbk. (JTPE) vs Organon Pharma Indonesia Tbk. (SCPI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Jasuindo Tiga Perkasa Tbk. vs Organon Pharma Indonesia Tbk. — how do they compare? Jasuindo Tiga Perkasa Tbk. trades at Rp605 (market cap 4.25T, 600.8K 24h volume), while Organon Pharma Indonesia Tbk. trades at Rp29,000 (market cap 104.4B). The key difference: Jasuindo Tiga Perkasa Tbk. is far larger — about 40.7× Organon Pharma Indonesia Tbk.'s market cap. Which is the better fit depends on your goals.
| JTPE | SCPI | |
|---|---|---|
Market Cap | 4.25T | 104.4B |
Volume | 600.8K | — |
Lot | 6.01K | — |
Turnover | 365.8M | — |
Average Price | 608.85 | — |
Value | 365.8M | — |
Indicative Equilibrium Price | 605 | — |
Indicative Equilibrium Volume | 2 | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Jasuindo Tiga Perkasa Tbk.
PT Jasuindo Tiga Perkasa Tbk (the Company) was established based on the Notarial Deed No. 122 dated November 10, 1990 of Susanti, SH., notary in Sidoarjo, Surabaya. On the first operation conduct in general printing specialize on business form printing. On 1996 got license to involve in security printing from BOTASUPAL (an institution under State Intelegent Inst)
Read more on JTPE →About Organon Pharma Indonesia Tbk.
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Read more on SCPI →
